DIFELIKALIN (Kapruvia®)

Clinical Indication

Moderate-to-severe pruritus associated with chronic kidney disease in adult patients on haemodialysis.

Date of classification

January 2023

Grey

Not yet reviewed drugs with no traffic light recommendation so not yet approved for use in LLR.

  • New medicines, devices, appliances.
  • New indication of existing medicine.
  • New NICE TA which has not been reviewed.
  • Not been requested for review by either TAS/LPT MMC.